OVACE Plus 100 mg/mL
SULFACETAMIDE SODIUM · LIQUID · Mission Pharmacal Company
Ovace Plus is a prescription liquid applied to the skin that contains sulfacetamide sodium, an antibiotic used to treat bacterial skin infections and acne. It is applied directly to affected areas of the skin as directed by your doctor.
Key Facts
- Brand Name
- OVACE Plus
- Generic Name
- SULFACETAMIDE SODIUM
- NDC Code (Product)
0178-0490- Manufacturer
- Mission Pharmacal Company
- Strength
- 100 mg/mL
- Dosage Form
- LIQUID
- Route
- TOPICAL
- Marketing Status
- Marketing Start
- 09/15/2011
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Full Prescribing Information
Indications & Usage
INDICATIONS: This product is intended for topical application in the following scaling dermatoses: seborrheic dermatitis and seborrhea sicca (dandruff). It also is indicated for the treatment of secondary bacterial infections of the skin due to organisms susceptible to sulfonamides.
Dosage & Administration
DOSAGE AND ADMINISTRATION: Seborrheic dermatitis including seborrhea sicca - Shake well before using. Apply to affected areas twice daily (morning and evening), or as directed by your physician. Avoid contact with eyes or mucous membranes. Repeat application as described for eight to ten days. As the condition subsides, the interval between applications may be lengthened. Applications once or twice weekly or every other week may prevent recurrence. Should the condition recur after stopping therapy, the application of this product should be reinitiated as at the beginning of treatment. Secondary cutaneous bacterial infections - Shake well before using. Apply to affected areas twice daily for eight to ten days.
Warnings
WARNINGS: Sulfonamides are known to cause Stevens-Johnson syndrome in hypersensitive individuals. Stevens-Johnson syndrome also has been reported following the use of sodium sulfacetamide topically. Cases of drug-induced systemic lupus erythematosus from topical sulfacetamide also have been reported. In one of these cases, there was a fatal outcome. KEEP OUT OF THE REACH OF CHILDREN.
Contraindications
CONTRAINDICATIONS: This product is contraindicated in persons with known or suspected hypersensitivity to any of the ingredients of the product. This product is not to be used by patients with kidney disease.
Adverse Reactions
ADVERSE REACTIONS: Reports of irritation and hypersensitivity to sodium sulfacetamide are uncommon. The following adverse reactions, reported after administration of sterile ophthalmic sodium sulfacetamide, are noteworthy: instances of Stevens-Johnson syndrome and instances of local hypersensitivity which progressed to a syndrome resembling systemic lupus erythematosus; in one case a fatal outcome was reported (see WARNINGS).
Frequently Asked Questions
What is OVACE Plus used for?
Ovace Plus is a prescription liquid applied to the skin that contains sulfacetamide sodium, an antibiotic used to treat bacterial skin infections and acne. It is applied directly to affected areas of the skin as directed by your doctor.
Is OVACE Plus a controlled substance?
OVACE Plus is not classified as a controlled substance by the DEA.
What is the generic name for OVACE Plus?
The generic name for OVACE Plus is SULFACETAMIDE SODIUM. There are 11 other brand versions of SULFACETAMIDE SODIUM.
What is the NDC code for OVACE Plus 100 mg/mL?
The NDC (National Drug Code) for OVACE Plus 100 mg/mL is 0178-0490, listed by Mission Pharmacal Company.
Other OVACE Plus Dosages
Other Sulfacetamide Brands
See all →- Sulfacetamide Sodium100 mg/mL76420-076
- Sumaxin CP43538-101
- Sodium Sulfacetamide, Sulfur100 mg/g44523-520
- SODIUM SULFACETAMIDE, SULFUR100 mg/g44523-604
- SULFACETAMIDE SODIUM98 mg/mL52187-553
- Sulfacetamide Sodium100 mg/mL76420-090
- Sodium Sulfacetamide 10 Sulfur 5 Cleanser10 mg/g42192-136
- Plexion98 mg/g44118-700
- Avar-e Green100 mg/g0178-0460
- SODIUM SULFACETAMIDE AND SULFUR100 mg/g44523-602
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)